This study suggests that AKR1B10 can induce radiotherapy resistance and promote cell survival via FFA/TLR4/NF-κB axis in NPC, which may provide a novel target to fight against radiotherapy resistance of NPC. This evidence concerns the gene AKR1B10 and nasopharyngeal carcinoma.